Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Tofersen treatment in respiratory onset amyotrophic lateral sclerosis and a variant of uncertain significance in SOD1; a case report

28 Jul 2026

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Cervical and Thoracic Myelopathy
Share to Neurogenetic and Muscular Disorders Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 42521811
DOI: 10.1038/s41431-026-02208-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Tofersen treatment in respiratory onset amyotrophic lateral sclerosis and a variant of uncertain significance in SOD1; a case reportPMID 42521811Read ↗

[Current Landscape of Tofersen in SOD-1-associated Amyotrophic Lateral Sclerosis].Semantic proximity Read ↗

Tofersen: A Review in Amyotrophic Lateral Sclerosis Associated with SOD1 Mutations.Semantic proximity Read ↗

Tofersen: First Approval.Semantic proximity Read ↗

ASO therapy for C9ORF72-related ALS/FTD.Semantic proximity Read ↗

Tofersen treatment in SOD1 p.Leu145Phe ALS: real-world outcomes in a genetically homogeneous Croatian cohort.Semantic proximity Read ↗

Serum Troponin T levels as a therapy response marker in SOD1-mediated ALSSemantic proximity Read ↗

Trial of Antisense Oligonucleotide Tofersen for SOD1 ALSSemantic proximity Read ↗

Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p.D91A variant in amyotrophic lateral sclerosis patientsSemantic proximity Read ↗

Recent Progress of Antisense Oligonucleotide Therapy for Superoxide Dismutase 1-mutated Amyotrophic Lateral Sclerosis: Focus on TofersenSemantic proximity Read ↗

Tofersen and other antisense oligonucleotides in ALSSemantic proximity Read ↗

Tofersen in SOD1-associated amyotrophic lateral sclerosis: From molecular mechanisms to regulatory milestones.Semantic proximity Read ↗

Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.